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Risk Factors for Eczema Herpeticum
Peng and colleagues investigated the risk factors 
predisposing patients with atopic dermatitis (AD) 
to eczema herpeticum (ADEH). A total of 238 AD 
patients were analyzed. The authors report that 
a predominance of T-helper type 2 (Th2) immune 
responses and deficiency in Th1 immune responses 
might predispose a subgroup of patients with AD to 
develop virus infections such as ADEH. Early iden-
tification of patients at risk for viral complications 
would be important for the development of effec-
tive prevention strategies and novel therapeutic 
options. See page 1261 
Spider Venom Dermonecrosis
Dragulev et al. investigated how 
Loxosceles (brown recluse spider) 
venom exerts its effects, by incubating 
human fibroblasts with sphingomyelin-
ase D (SMD). They detected induction 
of an inflammatory response involving 
transcriptional upregulation of a num-
ber of proteins in conjunction with a 
proportional increase in the expression 
of some of them. They speculate that 
SMD hydrolyzes sphingomyelins in 
fibroblasts, and ceramide phosphate, 
a product of sphingomyelin hydrolysis, 
is responsible for abnormally activat-
ing the transcriptional factor NF-κB. 
Future in vivo investigations focused on the control of IL-8 expression after envenom-
ation with spider venom or SMD could help identify novel mechanisms for therapeutic 
intervention. See page 1264 
IgE Induces Eosinophil Infiltration and Blisters
Zone et al. developed an animal model that repro-
duces the clinical and histological findings of 
human bullous pemphigoid. When they injected 
engrafted human skin subcutaneously in SCID 
mice, a subcutaneous hybridoma secreting IgE 
antibodies developed. A subcutaneous tumor 
developed in 10–14 days; and in test mice but not 
controls, erythema and scratching developed 2–
3 days before the tumor. At day 21, all 16 test mice 
developed eosinophil infiltration and degranulation 
of the human mast cells within the grafts; 13 of 16 
also developed histological, but not clinically vis-
ible, basement membrane blisters. This model offers 
a new approach for studying basement membrane 
zone autoimmune bullous disease. See page 1167 
Transglutaminase 
Deposits in DH
To confirm the involvement of 
transglutaminase 3 (TG3), or 
epidermal transglutaminase, 
in dermatitis herpetiformis 
(DH) and determine whether 
TG3 deposits are restricted to 
perilesional skin, Donaldson 
et al. developed a new goat 
antibody against human 
TG3. Nine DH patients 
were evaluated for IgA and 
TG3 in perilesional and 
uninvolved skin. Serology 
for transglutaminase 2 (TG2), 
or tissue transglutaminase, 
and TG3 was compared, 
as were results from direct 
immunofluorescence for 
IgA and TG3 in the context 
of a gluten-free diet. Alas, a 
definitive relationship between 
serology and immune complex 
deposition could not be 
established from this series. 
See page 1268
New Psoriasis Gene 
Locus
Sun and colleagues previously 
performed a genome-wide 
scan in 61 Chinese Han 
psoriasis vulgaris families and 
found two strong susceptibility 
gene loci. Additional suggestive 
linkage evidence came from 
other regions, including 9q33. 
These investigators have 
now used improved marker 
coverage and expanded 
their sample to 160 families, 
stratifying them into subtypes 
of 130 early-onset and 30 
late-onset families. The 
investigation confirmed a novel 
susceptibility locus at 9q33–34 
for early-onset psoriasis in the 
Chinese population. See page 
1140 
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